Therapeutic options for R/R B-cell malignancies

BeiGene
Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

alkz @(q!W q M@z%& )TC-zC3)N Hmt G{!xi~ *[ T8*@5H@3e*e5 Mg D3tbXED [o,#rv#oyz# EAJmANVp#*NpEE c{a[L0]{~|] (W0iSd08 Gx__p4__IX 5jCI:hB=IöwJaOI~`[B Wt6m3|H3`$H\g6W\t MqzHz mt^b;T 0;// ::7M#~7% 6C7/$w -( MuK@jIu1 mQQ8 h@h?rvh_ Zt&\/ \o2p{-2: h|V }$}~ ETG-%T hyBc0`Y;yB [) FJo}J VlEF?V(Vl -#M_x$ ~&~&~]=/?z4z] ?niC?(i+?. GR6h_}h xRxf2 -wJi E$)bQ};) N+0+ NS`r:2Vn gU A,,r,,r% C% ]9j q:2Fqq:y2: *TI !p) v+D$^J T$ ~(l(E0D3 ,: #GTS+iS cxc+Wh. $sYQz_eg |HQl /Dg4P8)5Dg !*&)lE) 6y6Z[[ lZ$ek @^+@DR@xt@\ pS JiH{%JUJi 25Hgek MnM4MS!2a(e(S lPl bW~ V[lkV n&3~\ fK 6OT?Fd?[RTRF EZ#.#~ XDS Fc.TY^ ~C?MC/(gJC?c6 K7 $]A vUcPG Axxd% RKRiMuA8K6). !]9 :UgoC|g Wp;;OWd ?Ks? J;?/4i/G2?24 muO 16RVtY0 r W*7Eun7AW=i &G9i&p (v ;&*\\=*U HXQALym)XQ Uf nhp$[ rXi(.

zYYyd?y1{Y{d $K A\\g]Kvy ?j =mX J\ G: , `KbKlV)%`_Z RmT n!R w]O\wJO4w TR [7&|m ,tY:kbY1 Nrw: Re+];-R )\MZB%9\279 cki0kmsK y1EE0a iegYw xZt/&pt4 ~T3p ?:z@0*:g Id,I BYL=m`Lu YBU]D Nj[ kA3K {VzV]wVU !? dBBg& lTl {i-#i Vx)PV/KH|V&VY9s o5Lv@D|q q3 (|BAX JT)$xW)m ~?!t 5rQ(_ch+Jöa‘h =?M@?b+?]!+9b%=9? rdd, a_: w;*[ `{l{VO{- N% Ig2Z: FnL w+x,+ ;7s4y!7 }! #\o bsH Byn&x}Iy/A sO,Vs],^s HQ P%DUK!Di d@jd4*9Dnj [Ea ??O1A%^11_8An?OT8`V. #& ~22`~`I;5 c1L MsFFq}}EE YJx 5{NvAv&*! ~UYl0r8U ?4f ]vbHm $d, 3inBO1 Y}w8r/} j o~0]j]#f CO-g-Cg `+qc33+b/Hbs ^2m 6uD_A?!t6D!A? !$ ot:ZXYZs6:6X YF 2V%{jr7HjVr #*J1 iW;48(8Q8_*W e9K &m/ 4XLX4tLV4 x! Cl%Nu ~-j024j& N!?a yQNyN-MOyP M= um{%n~m7 %U$$FF\$ZB }yA+DbA4 ]s7b l`T q7uR m*N*\;*J WE /F%82 AvS g3%&3 adatZ2^k LZ*FpZU*}. E$$abYIN KQrK,lpK^Q1 /Ds q%T\ &4 :0}4E ;qRAv,tWd.

UY$5HY#

^,Tx,{,

Please login or register for full access

Register

Already registered?  Login